Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
Division of Rhinology and Sinus/Skull Base Surgery, Oregon Sinus Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, U.S.A.|Department of Otolaryngology-Head and Neck Surgery, Emory University Hospital, Atlanta, Georgia, U.S.A.
Joshua M
JM
Levy
Division of Rhinology and Sinus/Skull Base Surgery, Oregon Sinus Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, U.S.A.
Timothy L
TL
Smith
D001241:Aspirin / Q000276:immunology*; D055963:Asthma, Aspirin-Induced / Q000150:complications / Q000276:immunology*; D002908:Chronic Disease; D003888:Desensitization, Immunologic; D006801:Humans; D009298:Nasal Polyps / Q000150:complications / Q000276:immunology*; D012220:Rhinitis / Q000150:complications / Q000276:immunology*; D012852:Sinusitis / Q000150:complications / Q000276:immunology*
D001241:Aspirin